Loading...

Creso Pharma Limited

COPHFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.12
$0.00(0.00%)

Creso Pharma Limited (COPHF) Company Profile & Overview

Explore Creso Pharma Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Creso Pharma Limited (COPHF) Company Profile & Overview

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOWilliam Lay

Contact Information

61 8 9389 3180
145 Stirling Highway, Nedlands, WA, 6009

Company Facts

IPO DateSep 7, 2017
CountryAU

Frequently Asked Questions

;